Showing results (491-500 of 589) with videos related to

Sort By:
Pageof 59
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2015
Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancerPeter Blume-Jensen, David M Berman, David L Rimm, et al.
The American Journal of Surgical Pathology|June 23, 2025
International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1: The ProstateKenneth A Iczkowski, Angelo M De Marzo, Neeraj Agarwal, et al.
Nature|March 25, 2011
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onsetCraig J Ceol, Yariv Houvras, Judit Jane-Valbuena, et al.
Advances in Radiation Oncology|April 20, 2026
The Association of p27 With Prostate Cancer Outcomes: A Secondary Analysis of NRG/RTOG 8610 and 9202Krishnan R Patel, Stephanie L Pugh, Jeffry P Simko, et al.
The Journal of Experimental Medicine|April 18, 2020
Targeting potential drivers of COVID-19: Neutrophil extracellular trapsBetsy J Barnes, Jose M Adrover, Amelia Baxter-Stoltzfus, et al.
Science (New York, N.Y.)|December 15, 2012
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independentKexin Xu, Zhenhua Jeremy Wu, Anna C Groner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2019
Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate CancerEmma H Allott, Ericka M Ebot, Konrad H Stopsack, et al.
Carcinogenesis|August 31, 2018
Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal diseaseThomas U Ahearn, Sam Peisch, Andreas Pettersson, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Distinct mesenchymal cell states mediate prostate cancer progressionHubert Pakula, Mohamed Omar, Ryan Carelli, et al.
Science (New York, N.Y.)|January 6, 2018
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinomaDiana Miao, Claire A Margolis, Wenhua Gao, et al.
Pageof 59